The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

1. Medina-Herrera, A.
2. Vazquez, I.
3. Cuenca, I.
4. Rosa-Rosa, J.M.
5. Ariceta, B.
6. Jimenez, C.
7. Fernandez-Mercado, M.
8. Larrayoz, M.J.
9. Gutierrez, N.C.
10. Fernandez-Guijarro, M.
11. Gonzalez-Calle, V.
12. Rodriguez-Otero, P.
13. Oriol, A.
14. Rosiñol, L.
15. Alegre, A.
16. Escalante, F.
17. De La Rubia, J.
18. Teruel, A.I.
19. De Arriba, F.
20. Hernandez, M.T.
21. Lopez-Jimenez, J.
22. Ocio, E.M.
23. Puig, N.
24. Paiva, B.
25. Lahuerta, J.J.
26. Bladé, J.
27. San Miguel, J.F.
28. Mateos, M.V.
29. Martinez-Lopez, J.
30. Calasanz, M.J.
31. Garcia-Sanz, R.
32. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/S41408-024-01053-3 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus